These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 23630050

  • 21. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R, Foley N, Pereira S, Sequeira K, Miller T.
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [Abstract] [Full Text] [Related]

  • 22. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity-III (ULIS-III) study group.
    J Rehabil Med; 2021 Jan 01; 53(1):jrm00133. PubMed ID: 33206198
    [Abstract] [Full Text] [Related]

  • 23. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT, Barden HL, Baguley IJ.
    J Rehabil Med; 2014 Oct 01; 46(9):864-8. PubMed ID: 25074437
    [Abstract] [Full Text] [Related]

  • 24. Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.
    Ashford S, Slade M, Turner-Stokes L.
    Disabil Rehabil; 2013 Aug 01; 35(18):1513-8. PubMed ID: 23294435
    [Abstract] [Full Text] [Related]

  • 25. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM, Bayle N, Goldberg S, Simpson DM.
    Arch Phys Med Rehabil; 2014 Jul 01; 95(7):1303-11. PubMed ID: 24709034
    [Abstract] [Full Text] [Related]

  • 26. Botulinum toxin should be first-line treatment for poststroke spasticity.
    Sheean G.
    J Neurol Neurosurg Psychiatry; 2009 Apr 01; 80(4):359. PubMed ID: 19289475
    [No Abstract] [Full Text] [Related]

  • 27. [The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury].
    Akulov MA, Hat'kova SE, Mokienko OA, Orlova OR, Usachev DY, Zakharov VO, Orlova AS, Tomskiy AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016 Apr 01; 116(8):30-35. PubMed ID: 27635608
    [Abstract] [Full Text] [Related]

  • 28. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV, Da Re C, Messineo I, Bonaiuti D.
    Eur J Phys Rehabil Med; 2015 Aug 01; 51(4):381-7. PubMed ID: 25358636
    [Abstract] [Full Text] [Related]

  • 29. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.
    J Rehabil Med; 2009 Jun 01; 41(7):536-44. PubMed ID: 19543664
    [Abstract] [Full Text] [Related]

  • 30. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 01; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 31. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 May 01; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A, Vallies G, Chemello E, Gavras A, Castellazzi P, Meschieri A, Serina A, Gandolfi M, Baricich A, Santamato A, Cisari C, Smania N.
    J Rehabil Med; 2017 May 16; 49(5):410-415. PubMed ID: 28471469
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 May 16; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.